AVTX vs UBER · P/E 0.0, rev $441.0K vs P/E 18, rev $52.02B
Avalo Therapeutics Inc (AVTX) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the AVTX and UBER stock pages for the full models.
Not investment advice.